Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 01, 2013 08:00 ET | Source: Novavax, Inc.

Novavax Reports Fourth Quarter and Year-End 2012 Financial Results

ROCKVILLE, Md., March 1, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced financial results for the fourth quarter and year-ended December 31, 2012. For the fourth quarter of...
February 22, 2013 14:55 ET | Source: Novavax, Inc.

Novavax to Report 2012 Fourth-Quarter and Year-End Financial Results on March 1, 2013

ROCKVILLE, Md., Feb. 22, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2012 fourth-quarter and year-end financial results on Friday, March 1, 2013,...
February 07, 2013 08:00 ET | Source: Novavax, Inc.

NOVAVAX to Present at the 15th Annual Bio CEO & Investor Conference

ROCKVILLE, Md., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Frederick W. Driscoll, Vice President and Chief Financial Officer of...
January 24, 2013 08:00 ET | Source: Novavax, Inc.

BARDA Continues Novavax' Influenza Vaccine Programs Following In-Process Review

ROCKVILLE, Md., Jan. 24, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development...
December 06, 2012 16:01 ET | Source: Novavax, Inc.

Novavax' Phase I RSV Vaccine Data Published in Vaccine

Vaccine was well-tolerated with no evident dose-related toxicity or attributable SAEs Immunization induced significant increases in neutralizing antibody responses ROCKVILLE, Md., Dec. 6,...
December 03, 2012 10:11 ET | Source: Novavax, Inc.

Novavax Publishes Preclinical Efficacy Study of its RSV Protein Nanoparticle Vaccine Candidate

ROCKVILLE, Md., Dec. 3, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that the journal PLOS ONE (http://dx.plos.org/10.1371/journal.pone.0050852) published data from a...
November 20, 2012 17:06 ET | Source: Novavax, Inc.

Novavax to Present at the 24th Annual Piper Jaffray Healthcare Conference

ROCKVILLE, Md., Nov. 20, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
November 12, 2012 08:00 ET | Source: Novavax, Inc.

Novavax to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

ROCKVILLE, Md., Nov. 12, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
November 02, 2012 08:00 ET | Source: Novavax, Inc.

Novavax Reports Third-Quarter 2012 Financial Results

ROCKVILLE, Md., Nov. 2, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced financial results for the third quarter and nine months ended September 30, 2012. Third-Quarter 2012 and...
October 26, 2012 08:00 ET | Source: Novavax, Inc.

Novavax to Report Third Quarter 2012 Financial Results on November 2, 2012

ROCKVILLE, Md., Oct. 26, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2012 third-quarter financial results on Friday, November 2, 2012, before the U.S....